Feedback / Questions
Campath (alemtuzumab) - Sanofi
etivelcabtagene erigedleucel (UCART20x22) - Cellectis
http://clinicaltrials.gov/ct2/show/NCT05607420
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next